drugset / Trial / NCT01594619

Study in Healthy Volunteers to Investigate the Effects of Diltiazem on the Pharmacokinetics of Naloxegol

NCT01594619

Phase 1 Completed 44 enrolled AstraZeneca
Non-randomizedCrossoverOpen-labelBasic science

Summary

Study in healthy volunteers to investigate the effects of Diltiazem on the Pharmacokinetics of naloxegol.

Timeline

Start
2012-05
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diltiazem XR Unknown 240 mg Oral
Subject Naloxegol Small molecule 25 mg Oral

Indications